Bryan Johnson has a real disease, and most of what he says about it is accurate. That is the part worth stating first, because it is easy to roll your eyes at the man who measures his own erections and drinks his son's plasma and miss that the underlying medicine here is sound. In May he was diagnosed with autoimmune gastritis after a stomach biopsy. His immune system is attacking the parietal cells in the body of his stomach, the ones that make acid and intrinsic factor. That attack is well described in the literature. The mechanism is CD4 T-cells and autoantibodies going after the H+/K+-ATPase proton pump and intrinsic factor, which strips out stomach acid, wrecks iron absorption, and eventually starves the body of B12.
His account of how it hides is correct and, honestly, useful. The earliest sign is often low ferritin while hemoglobin and hematocrit still read normal, so a busy clinician sees no anemia and moves on. A colonoscopy will never find it, because it looks at the wrong end of the gut. You need an upper endoscopy with biopsies sampled from the right places, following the Sydney protocol, or the disease sits there for years doing quiet damage. Johnson traces his back to a hypothyroidism diagnosis at 21, and that link is documented too. The thyro-gastric cluster is a known thing. Hashimoto's and autoimmune gastritis travel together often enough that endocrinologists watch for it. Whether the thyroid problem caused the stomach one or both grew from the same susceptibility is an association, not a proven sequence, but the connection is not something he made up.
The cancer warning also holds. Autoimmune gastritis raises the risk of gastric adenocarcinoma and, more sharply, type 1 gastric neuroendocrine tumors, driven by the high gastrin that follows loss of acid. STAT's reporting puts the neuroendocrine risk at roughly 13 times baseline. That is the reason for endoscopic surveillance, and it is a fair reason to take the diagnosis seriously rather than shrug at it.
Where the science ends and the pitch begins
Then comes the word cure, and the plan behind it, and this is where I want to be precise rather than dismissive. Steps zero through four are grounded. Single-cell sequencing of a million immune cells, reading the receptor on each T-cell to find clonally expanded populations, is an established research technique. Isolating the pathogenic clone from blood alone is genuinely hard, which is why his instinct to go back for live tissue is correct: the autoantibodies prove an attack is happening, but the T-cell doing the damage tends to live in the stomach lining, not the bloodstream. Cryopreserving his own immune cells is routine lab practice. Building a dish-based model of his cells to test drugs before they enter his body is a real and growing field, organoids and organ-on-chip work, though it is research-stage and always a simplified copy of the living system, never the whole thing.
Step three, the biweekly blood draws paired with wearable data to catch flares before he feels them, is the weakest of the grounded steps. Wearables predicting flares has decent evidence in inflammatory bowel disease and rheumatoid arthritis. For autoimmune gastritis specifically there is no validated wearable signal at all. He is extrapolating from adjacent diseases and calling it a system.
Step five is the one his followers latched onto, and it is the one furthest from a clinic. His four therapy paths map cleanly onto real immunology programs he did not invent. Restoring tolerance and teaching the rogue cells to stand down is antigen-specific immunotherapy and regulatory T-cell work, active in type 1 diabetes and Graves', with nothing approved as a cure yet. The engineered cells that hunt down the autoreactive ones are CAR-T and, more precisely, CAAR-T, chimeric autoantibody receptor T-cells that were designed to selectively delete antigen-specific B-cells. That concept was published in Science in 2016 and first aimed at pemphigus vulgaris, with early trials like RESET-PV now running and Graves' work in the pipeline. Promising, yes. Early, risky, and unproven for his disease, also yes.
The claim that nobody has done this
Johnson writes that to his knowledge no one has ever done this to try to cure an autoimmune disease. Read literally that is false, because every component he lists comes from labs that have been at it for years. The most charitable and probably intended reading is that no one has assembled exactly this combination as an n-of-1 protocol on a single wealthy person willing to pay for all of it. That is likely true and also not the triumph it sounds like. An experiment with one subject, no control, and the subject funding and narrating the whole thing is the weakest possible design for learning whether anything worked. If his stomach improves, we will not know if it was the therapy, the natural waxing and waning of the disease, or the very good care he takes of himself, which he credits, correctly, for keeping his case mild.
To his credit, he pushed back publicly on the flood of replies telling him to eat carnivore, chase sunlight, or megadose vitamin D. He said his vitamin D was fine and that those fixes were unlikely to matter. He is right. There is no evidence that akkermansia, zinc carnosine, beef and butter, fasting, or B12 shots cure autoimmune gastritis. B12 and iron replacement manage the deficiency. They do not call off the immune attack. On that specific point Johnson is a better guide than his audience.
What this is really about
Millions undiagnosed is a plausible line. Population prevalence estimates land somewhere around two to five percent depending on the population and the method, and the disease is silent for years, so a large undiagnosed pool is a reasonable inference. Present it as an estimate, not a hard count, because that is what it is.
What sits with me is the access question that neither Johnson nor the breathless coverage wants to sit with. A protocol that involves sequencing a million of your own immune cells, repeat targeted biopsies, cryopreserved cell banks, a bespoke dish model of your immunity, and custom cell therapy is affordable to almost no one on Earth. The useful public-health fact buried in his thread is the cheap one: low ferritin with normal hemoglobin deserves an upper endoscopy, and doctors miss autoimmune gastritis because they stop at the blood count. That single habit, applied to ordinary patients in ordinary clinics, would catch more disease than any dish-grown model of one man's immune system ever will. The frontier immunology is real. The cure is a hypothesis he is testing on himself, and the sooner it is called that instead of a cure, the more honest the whole thing becomes.